Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features
Tóm tắt
Primary hyperparathyroidism (PHPT) is characterized most commonly now as an asymptomatic disorder with hypercalcaemia and elevated levels of parathyroid hormone (PTH). The elevation in PTH is detected by both the standard immunoradiometric assays (IRMA) and a more recent IRMA that detects only the 1–84 full‐length PTH molecule. The serum calcium concentration is usually <1 mg dL−1 above normal. Recently, another variant of PHPT (normocalcaemic PHPT) has been described in which the serum calcium is normal but the serum PTH is elevated, in the absence of any secondary cause for PTH elevation. Although usually sporadic, PHPT also occurs in inherited syndromes. Skeletal manifestations are appreciated by densitometry showing a typical pattern in which cancellous bone of the lumbar spine is reasonably well preserved whilst the cortical bone of the distal third of the radius is preferentially reduced. Although reduced in incidence, renal stones remain the most common overt complication of PHPT. Other organs are theoretical targets of PHPT such as the neurobehavioural axis and the cardiovascular system. Vitamin D looms as an important determinant of the activity of the PHPT state. The 2002 NIH Workshop on asymptomatic PHPT has led to revised guidelines to help doctors determine who is best advised to have parathyroid surgery and who can be safely followed without surgery. New information about the natural history of PHPT in those who did not undergo surgery has helped to define more precisely who is at‐risk for complications. At the NIH workshop, a number of items were highlighted for further investigation such as pharmacological approaches to controlling hypercalcaemia, elevated PTH levels and maintaining bone density.
Từ khóa
Tài liệu tham khảo
Geelhoed GW, 1989, Pseudogout as a clue and complication in primary hyperparathyroidism, Surgery, 106, 1036
Marx SJ, 2002, Hyperparathyroidism in hereditary syndromes: special expressions and special managements, J Bone Miner Res, 17, N37
Lepage R, 1998, A non(1–84)‐circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples, Clin Chem, 44, 805, 10.1093/clinchem/44.4.805
John MR, 1999, A novel immunoradiometric assay detects full‐length human PTH but not amino‐terminally truncated fragments: implications for PTH measurement in renal failure, J Clin Endocrinol Metab, 84, 4287, 10.1210/jcem.84.11.6236
Bilezikian JP, 1991, Characterization and evaluation of asymptomatic primary hyperparathyroidism, J Bone Miner Res, 6, 585
Parfitt AM., 1989, Clinical Disorders of Bone and Mineral Metabolism, 7
Bilezikian JP., 2003, Bone strength in primary hyperparathyroidism, Osteoporos Int, 14, 5113
Silverberg SJ., 2003, Non‐classical target organs in primary hyperparathyroidism, J Bone Miner Res, 17, N117
Joborn C, 1998, Psychiatric morbidity in primary hyperparathyroidism, World J Surg, 2, 476
Clark OH., 1994, Presidential address: ‘Asymptomatic’ primary hyperparathyroidism: is parathyroidectomy indicated, Surgery, 116, 947
Brown GG, 1987, Neurobehavioral symptoms in mild hyperparathyroidism: related to hypercalcemia but not improved by parathyroidectomy, Henry Ford Med J, 35, 211
Diamond TH, 1987, Hypercalcemia due to parathyroid adenoma and hypertrophic cardiomyopathy, S Afr Med J, 71, 448
Niederle B, 1990, Cardiac calcific deposits in patients with primary hyperparathyroidism: preliminary results of a prospective echocardiographic study, Surgery, 108, 1052
Rubin MR, 2002, Vascular stiffness is increased in patients with primary hyperparathyroidism, J Bone Miner Res, 17, S381
Norton JA, 1987, Effect of parathyroidectomy in patients with Zollinger‐Ellison syndrome and MEN1. A prospective study, Surgery, 102, 958
Meng XW, 1994, The diagnosis of primary hyperparathyroidism – analysis of 134 cases, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 16, 13
Silverberg SJ, Vitamin D deficiency in primary hyperparathyroidism, Am J Med, 107, 561, 10.1016/S0002-9343(99)00294-6
Palmer M, 1987, Mortality after surgery for primary hyperparathyroidism. A follow‐up of 441 patients operated on from 1956 to 1979, Surgery, 102, 1
National Institutes of Health., 1991, Consensus development conference statement on primary hyperparathyroidism, J Bone Miner Res, 6, s9
Bilezikian JP, 2002, Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century, J Bone Miner Res, 17, N2
Colli E, 2004, Forearm autograft recurrence after 37 consecutive total parathyroidectomies for primary hyperparathyroidism in MEN1 syndrome, J Intern Med, 255, 715
Marx SJ., 2001, The Metabolic and Molecular Bases of Inherited Disease, 943
Norton KS, 2001, Use of the Sestamibi scan to identify hyperplastic parathyroid tissue in the forearm of a patient with MEN1 syndrome, J La State Med Soc, 153, 605
Deaconson TF, 1987, The effect of parathyroidectomy on the recurrence of nephrolithiasis, Surgery, 215, 241
Tritos NA, 1999, Rapid improvement of osteoporosis following parathyroidectomy in a premenopausal woman with acute primary hyperparathyroidism, Arch Intern Med, 139, 1498
DiGregorio S., 1999, Hiperparatiroidismo primario: dramatico incremento de la masa ostea post paratiroidectomia, Diagn Osteol, 1, 11
Parfitt AM, 1991, Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention, J Bone Miner Res, 6, S97
Marcus R., 2002, The role of estrogens and related compounds in the management of primary hyperparathyroidism, J Bone Miner Res, 17, N146